The monitoring of minimal residual disease in patients with malignant tumors.
Reizenstein
P
P
D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D005500:Follow-Up Studies; D006801:Humans; D007938:Leukemia / Q000175:diagnosis; D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy; D010257:Paraneoplastic Syndromes / Q000175:diagnosis*
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor